INFI

Infinity Pharmaceuticals, Inc.
INFI

Overview Fund Activity
Delisted

INFI was delisted on the 13th of September, 2023.

Back to rankings

118 hedge funds and large institutions have $606M invested in Infinity Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 29 increasing their positions, 40 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+20
Holders Change %
+20.41%
% of All Funds
3.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
29
Increased
29
Reduced
40
Closed
9
Calls
$12.9M
Puts
$24.2M
Net Calls
-$11.3M
Net Calls Change
-$4.94M

Top Buyers

1
BB
BB Biotech
Switzerland
+$10.9M
2
Millennium Management
Millennium Management
New York
+$9.9M
3
BIM
Bogle Investment Management
Massachusetts
+$6.27M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$5.4M
5
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$4.32M

Top Sellers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
-$23M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$21.7M
3
BC
Broadfin Capital
New York
-$7.84M
4
Franklin Resources
Franklin Resources
California
-$5.68M
5
Norges Bank
Norges Bank
Norway
-$4.61M
Name Holding Trade Value Shares
Change 		Shares
Change %
VFA
126
Virtus Fund Advisers
Connecticut
– -$53K -4,142 Closed
Bank of Montreal
127
Bank of Montreal
Ontario, Canada
– -$15K -1,200 Closed
2 3 4 5
6